Evidence map›Paper›PMID 26951766›Full record

ArticleScientific reports2016

Quantitative proteomics study of the neuroprotective effects of B12 on hydrogen peroxide-induced apoptosis in SH-SY5Y cells.

Lijun Zhong, Juntuo Zhou, Xi Chen, Yaxin Lou, Dan Liu, Xiajuan Zou, Bin Yang, Yuxin Yin, Yan Pan

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Evodiamine derivatives improve cognitive abilities in APPAnimal models and experimental medicine · 2020
    Article
  13. Article
  14. Article
  15. Neural regeneration research · 2019
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Lijun ZhongMedical and Health Analytical Center, Peking University Health Science Center, Beijing 100191, China.
Juntuo ZhouDepartment of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Xi ChenMedical and Health Analytical Center, Peking University Health Science Center, Beijing 100191, China.
Yaxin LouMedical and Health Analytical Center, Peking University Health Science Center, Beijing 100191, China.
Dan LiuMedical and Health Analytical Center, Peking University Health Science Center, Beijing 100191, China.
Xiajuan ZouMedical and Health Analytical Center, Peking University Health Science Center, Beijing 100191, China.
Bin YangMedical and Health Analytical Center, Peking University Health Science Center, Beijing 100191, China.
Yuxin YinInstitute of Systems Biomedicine, Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
Yan PanDepartment of Pharmacology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B12 belongs to the coumarin class of compounds that have been shown to have various physiological and pharmacological activities including anti-inflammatory, antibacterial, and antioxidant. In the present study, we characterised the neuroprotective effects of B12 against H2O2-induced neuronal cell damage in SH-SY5Y cells. Protein expression profiling in combination with pathway analysis was deployed to investigate the molecular events associated with the neuroprotective effects in human neuronal cells using a label-free quantitative proteomics approach. A total of 22 proteins were significantly differentially expressed in H2O2-damaged cells with or without B12 treatment. Bioinformatics analysis using the Cytoscape platform indicated that poly pyrimidine tract binding protein 1 (PTBP1) was highly associated with the protective effect, and western blotting verified that PTBP1 was up-regulated in H2O2 + B12 treatment group, compared with the H2O2 treated group. PTBP RNAi experiments knocked down PTBP expression, which cancelled out the protective effect of B12 on cell viability. Thus, we infer that B12 neuroprotective activity involves up-regulation of PTBP1 and its associated signalling networks following H2O2-induced apoptosis in SH-SY5Y cells. B12 or related compounds may prove to be useful therapeutic agents for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's.

Indexed as

Anti-Inflammatory AgentsAntioxidantsApoptosisCell Line, TumorCell SurvivalCobamidesHeterogeneous-Nuclear RibonucleoproteinsHumansHydrogen PeroxideNeuroblastomaNeurodegenerative DiseasesNeuroprotective AgentsOxidative StressPolypyrimidine Tract-Binding ProteinProteomicsRNA InterferenceAnti-Inflammatory AgentsAntioxidantsCobamidesHeterogeneous-Nuclear RibonucleoproteinsHydrogen PeroxideNeuroprotective AgentsPolypyrimidine Tract-Binding ProteinPTBP1 protein, humanRNA, Small Interfering

Identifiers

PMID26951766
PMCPMC4782069
OpenAlexW2293134363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.